Robert James Adam

Dr. Robert James Adam serves as a Senior Lecturer and Clinical Trials Specialist at the University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine. He is a behavioural neurologist specializing in cognition and movement disorders, with clinical leadership roles in deep brain stimulation at The Royal Brisbane & Women's Hospital and statewide services for Huntington's Disease, Friedreich's Ataxia, and Parkinson's Disease.

His research spans clinical trials of novel therapies for neurodegenerative disorders, particularly antisense oligonucleotides for Huntington's Disease (PRECISION-HD trials) and drug repurposing in Parkinson's Disease. Collaborating across UQ and national networks, his work integrates clinical neuroscience with molecular immunology, neuroimaging, and cognitive assessment. Recent publications reveal strong focus on biomarker discovery, diagnostic accuracy in dementia, and neuromodulation mechanisms.

Dr. Adam contributes to national initiatives including the NHMRC-funded Australian Dementia Network (ADNet) and previously served as research officer in the Prospective Imaging Study of Ageing (PISA). His academic leadership extends to medical education for undergraduates and graduates, alongside supervision of higher degree candidates.

• Principal Investigator: PRECISION-HD1 & 2 clinical trials for Huntington's Disease
• Clinical Lead: Metro North Deep Brain Stimulation Program
• Statewide Service Lead: Huntington's Disease and Friedreich's Ataxia
• Collaborator: Nationwide Parkinson's drug repurposing initiative

His clinical expertise is complemented by extensive international training across neurology centers in the US, UK, and Australia, with ongoing commitment to translating research into improved patient care pathways for movement and cognitive disorders.